Asthma
Feature
COVID-19 has brought more complex, longer office visits
Patients’ increased mental health needs and worsened chronic conditions have practices playing catch-up and expanding teams to ease demand.
From the Journals
Itepekimab reduces loss of asthma control
From the Journals
Placebo beat risankizumab in adults with severe asthma
From the Journals
Synthetic chemical in consumer products linked to early death, study says
Daily exposure to phthalates may lead to hundreds of thousands of early deaths each year among older adults in the United States.
From the Journals
EAACI review urges reduction in antibiotic overuse with allergy
Conference Coverage
Tezepelumab reduces serious exacerbations in severe asthma
News
List of COVID-19 high-risk comorbidities expanded
Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.
Conference Coverage
Asthma-COPD overlap linked to occupational pollutants
The prevalence and clinical features of asthma-COPD overlap are understudied.
Conference Coverage
Novel agent shows promise against cat allergy
“We clearly demonstrate that these antibodies decrease the asthmatic response to cat allergen within 8 days, and that these effects last 3 months...
Conference Coverage
Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbidities
Few studies have examined the efficacy of mepolizumab therapy for patients with asthma and comorbidities.
Conference Coverage
Patients with asthma say most doctors don’t ask about cannabis use
Smoking cannabis could lead to increased symptoms of cough and wheeze.